136 related articles for article (PubMed ID: 31702049)
1. Increased frequency of CD4
Elston L; Fegan C; Hills R; Hashimdeen SS; Walsby E; Henley P; Pepper C; Man S
Br J Haematol; 2020 Mar; 188(6):872-880. PubMed ID: 31702049
[TBL] [Abstract][Full Text] [Related]
2. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia.
Manukyan G; Turcsanyi P; Mikulkova Z; Gabcova G; Urbanova R; Gajdos P; Smotkova Kraiczova V; Zehnalova S; Papajik T; Kriegova E
Leuk Res; 2018 Sep; 72():113-119. PubMed ID: 30149317
[TBL] [Abstract][Full Text] [Related]
4. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
[TBL] [Abstract][Full Text] [Related]
5. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
Lim A; French MA; Price P
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
[TBL] [Abstract][Full Text] [Related]
6. Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS.
de Goeje PL; Klaver Y; Kaijen-Lambers MEH; Langerak AW; Vroman H; Kunert A; Lamers CHJ; Aerts JGJV; Debets R; Hendriks RW
Front Immunol; 2018; 9():2034. PubMed ID: 30245692
[No Abstract] [Full Text] [Related]
7. Prognostic significance of PD-1 expression on peripheral blood CD4+ T cells in patients with newly diagnosed chronic lymphocytic leukemia.
Rusak M; Eljaszewicz A; Bołkun Ł; Łuksza E; Łapuć I; Piszcz J; Singh P; Dąbrowska M; Bodzenta-Łukaszyk A; Kłoczko J; Moniuszko M
Pol Arch Med Wewn; 2015; 125(7-8):553-9. PubMed ID: 26140546
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
[TBL] [Abstract][Full Text] [Related]
9. Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia.
Tonino SH; van de Berg PJ; Yong SL; ten Berge IJ; Kersten MJ; van Lier RA; van Oers MH; Kater AP
Leuk Lymphoma; 2012 Sep; 53(9):1785-94. PubMed ID: 22397719
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract][Full Text] [Related]
11. CD4
Piersiala K; Farrajota Neves da Silva P; Hjalmarsson E; Kolev A; Kågedal Å; Starkhammar M; Elliot A; Marklund L; Margolin G; Munck-Wikland E; Kumlien Georén S; Cardell LO
Cancer Sci; 2021 Mar; 112(3):1048-1059. PubMed ID: 33462898
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
[TBL] [Abstract][Full Text] [Related]
13. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.
Serrano D; Monteiro J; Allen SL; Kolitz J; Schulman P; Lichtman SM; Buchbinder A; Vinciguerra VP; Chiorazzi N; Gregersen PK
J Immunol; 1997 Feb; 158(3):1482-9. PubMed ID: 9013995
[TBL] [Abstract][Full Text] [Related]
14. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.
Tötterman TH; Carlsson M; Simonsson B; Bengtsson M; Nilsson K
Blood; 1989 Aug; 74(2):786-92. PubMed ID: 2787679
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of follicular T helper cells and their association with therapeutic effects in patients with chronic lymphocytic leukaemia.
Qiu L; Zhou Y; Yu Q; Zheng S; Wang Z; Huang Q
Immunol Lett; 2018 May; 197():15-28. PubMed ID: 29526569
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
17. Numbers of CD8+PD-1+ and CD4+PD-1+ Cells in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage and Are Significantly Higher Compared to Healthy Volunteers.
Novák M; Procházka V; Turcsányi P; Papajík T
Acta Haematol; 2015; 134(4):208-14. PubMed ID: 26066608
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.
Jadidi-Niaragh F; Ghalamfarsa G; Memarian A; Asgarian-Omran H; Razavi SM; Sarrafnejad A; Shokri F
Tumour Biol; 2013 Apr; 34(2):929-40. PubMed ID: 23269607
[TBL] [Abstract][Full Text] [Related]
19. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
20. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]